Stay updated with breaking news from Robertl Ferris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Targeted Oncology™, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of...
Comparable progression-free survival was observed in intermediate-risk patients with HPV and oropharynx cancer who received less intense postoperative radiation therapy, without chemotherapy.
PITTSBURGH, Nov. 3, 2021 – Radiation can be a powerful cancer therapy, but it doesn’t work for everyone. A new study identifies tumor features linked
E-Mail New research results for patients with breast and HPV-associated throat cancers are the highlights among 23 presentations by ECOG-ACRIN Cancer Research Group researchers at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, occurring virtually June 4-8. The National Cancer Institute (NCI), part of the National Institutes of Health, funded these studies. Breast Cancer Platinum chemotherapy fails in phase III trial for triple-negative breast cancer, basal-like subtype Abstract 605: About 80% of triple-negative breast cancers (TNBC) are a subtype called 'basal-like....
First Patient Treated in Phase II Combination Trial of ISA Pharmaceuticals' Lead Immunotherapy ISA101b with Keytruda® Combination aimed at priming and driving durable patient immune responses to cancer News provided by Share this article Share this article LEIDEN, The Netherlands, Jan. 26, 2021 /PRNewswire/ -- ISA Pharmaceuticals B.V., a clinical-stage company dedicated to developing rationally designed immunotherapeutics for oncology and infectious disease, today announced that the first patient has been dosed with its lead product ISA101b in a Phase II trial conducted and sponsored by UPMC...